Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...
Crimes can happen at any time and place under varying circumstances. When crimes do occur, it is the responsibility of the investigators to identify the perpetrators and bring them to justice.
For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk ...
President Trump repealed outgoing President Biden's Executive Order that established comprehensive guidelines for the ...
The Managing Director, DNA-Harley and Rainbow Specialised Laboratory, Dr Ademolu Owoyele, has called for the introduction of ...
The pair could face immediate resistance at 1.0390-1.0400, where the 200-period Simple Moving Average (SMA) meets the ...
A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...
Humor is emerging as a revealing lens for understanding bias within artificial intelligence systems. A new study published in ...
New research reveals the concerning impact of AI bias on human judgment. Find out how AI systems can amplify and compound ...
Only 61% of hospitals using AI or a predictive model report evaluating for accuracy using local data, and just 44% do so for bias, according to a recent study. Analyses suggest that hospitals with ...
In this week's Legal Speak episode, Judge Josh Thacker, who presides over the Spalding County State Court in west central Georgia, opens up about a tradition he engages in every Dr. Martin Luther King ...
The US Food and Drug Administration (FDA) recently issued its draft guidance, Artificial Intelligence-Enabled Device Software Functions: ...